
Academic Journal
Q2Frontiers in Genetics
About Frontiers in Genetics
Frontiers in Genetics is a scholarly journal published by Frontiers Media SA. SCImago 2025 lists it in Q2, with an SJR of 0.833 and H-index of 147.
Coverage: 2010-2026. Research categories: Genetics (Q2); Genetics (clinical) (Q2); Molecular Medicine (Q2).
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2026-03-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Cancer-related molecular mechanisms research; RNA modifications and cancer; Ferroptosis and cancer prognosis; Genetic and phenotypic traits in livestock; MicroRNA in disease regulation; Epigenetics and DNA Methylation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Longitudinal single-cell analysis identifies a chemotherapy-suppressed proliferative program associated with adverse prognosis in neuroblastoma
Aiguo Zhu, Jian Wang
2026-10-02 · DOI: 10.3389/fgene.2026.1878093Clinical and genetic features, surgical management, and longitudinal follow-up in two children with progressive osseous heteroplasia
Yuehan Yin, Binshan Zhao, Liying Sun, Wenyao Zhong et al.
2026-10-02 · DOI: 10.3389/fgene.2026.1883125Endocardial thickening in dilated cardiomyopathy associated with FHL2 variant: a case report
Yana Wang, Lingfang Liang, Lingke Liu, Jiajia Ren et al.
2026-10-02 · DOI: 10.3389/fgene.2026.1841224Forensic characteristics and genetic variations of Han Chinese population in Shenzhen revealed by 23 autosomal STRs
Litao Wu, Renhui Jiang, Xinyue Liu, Yinming Zhang et al.
2026-10-02 · DOI: 10.3389/fgene.2026.1931015Case Report: McLeod syndrome caused by a nonsense variant c.484C > T (p.Gln162Ter) in the XK gene in a Chinese Han family
Luochu Dong, Mange Liu, Ying Tan
2026-10-01 · DOI: 10.3389/fgene.2026.1939479Exploring the potential targets and possible mechanisms of Shenqi Fuzheng Injection in the treatment of cancer-associated muscle wasting based on network pharmacology
Chen Liu, Ling Cheng, Wenfeng Ye, Lina Zhang et al.
2026-10-01 · DOI: 10.3389/fgene.2026.1876819A pilot genome-wide association study of ischemic heart disease with co-occurring arterial hypertension in a Kazakh cohort
Liliya Skvortsova, Kanagat Yergali, Assel Zhaxylykova, Mamura Begmanova et al.
2026-10-01 · DOI: 10.3389/fgene.2026.1927147From inherited susceptibility to tumor state: toward a stage-aware architecture for genomic risk stratification in prostate cancer
Ziheng Zheng, Xuechun Yang, Minqian Ou, Yuedong Chen et al.
2026-10-01 · DOI: 10.3389/fgene.2026.1969511Burden of pathogenic variants in genes associated with medically actionable disease in the Slovenian population
Urška Kotnik, Luca Lovrecic, Borut Peterlin
2026-10-01 · DOI: 10.3389/fgene.2026.1847596M6A modification in lipid metabolism and related diseases
Zhiwen Hu, Didi Yuan, Xi Feng, Sai Hu et al.
2026-10-01 · DOI: 10.3389/fgene.2026.1890451From ISO 9001:2015 to ISO 20387:2018: a proposed implementation roadmap for biobanks
Michael Zuniga, Denis Marino, Gabriele Hartl, Berthold Huppertz et al.
2026-09-30 · DOI: 10.3389/fgene.2026.1953941Bioinformatic prediction, qCLASH, and AlphaFold3 reveal non-overlapping layers of the miR-214-3p–mRNA interactome
Jia Yao, Bingqiao Huang, Chenyu Chang, Ziqi Lin et al.
2026-09-30 · DOI: 10.3389/fgene.2026.1924314A novel matrix multiplication framework for modeling genotype-by-environment interaction in genomic prediction
Osval A. Montesinos-López, Abelardo Montesinos-López, Cricelio Montesinos-Lopez, José Crossa et al.
2026-09-29 · DOI: 10.3389/fgene.2026.1961511HOTAIR regulates osteogenic–adipogenic differentiation imbalance through the miR-217/DKK1-mediated Wnt/β-catenin pathway in SONFH-BMSCs
Min Yi, Feifei Lin, Zhenwu Du, Qingyu Wang et al.
2026-09-29 · DOI: 10.3389/fgene.2026.1917162Cellular, chromatin-accessibility, and spatial contextualization of bulk transcriptional patterns linked to positive peritoneal cytology in endometrial cancer
Jiangang Huang, Binglai Luo, Zhiqing Hu, Shuping Lin et al.
2026-09-29 · DOI: 10.3389/fgene.2026.1924936Mechanisms for the formation and maintenance of microhabitat self-organization in the root system of orchid
Junyang Song, Xinying Hao, Jianfeng Chen, Shankang Wang et al.
2026-09-29 · DOI: 10.3389/fgene.2026.1809943Quantitative analysis of proteostasis disruption following siRNA-mediated HSP70 depletion in HeLa cells
Hatice Esenkaya
2026-09-28 · DOI: 10.3389/fgene.2026.1856671Chromatin remodeling in bone organoids: from epigenetic regulation to disease modeling and therapeutic translation
Yuxin Zheng, Desheng Liu, Jun Hou, Hong Ding et al.
2026-09-28 · DOI: 10.3389/fgene.2026.1975296Alzheimer’s disease diagnosis based on gene selection and cross-tissue validation
Xiaolan Zhang, Xiaotong Tang, Qian Bo, Yu Ma et al.
2026-09-28 · DOI: 10.3389/fgene.2026.1890236Integrative bioinformatics screening of a M2 macrophage-associated gene signature for osimertinib resistance
Yajie Huang, Yaozhong Zhang, Jian Shi
2026-09-28 · DOI: 10.3389/fgene.2026.1928986Reviews
Community Reviews
Version History
October 2, 2026 at 8:41 pm
October 2, 2026